Insulin-Price Increases Reflect Role of Health-Care Middlemen

Insulin prices are soaring, creating pain for patients whose life depends on the injectable drug —yet most of the revenue from the increases isn’t going to the drug manufacturers, it is largely being collected by the middlemen.

Source: WSJ.com: Health - October 10, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news